Search details
1.
Noninvasive detection of any-stage cancer using free glycosaminoglycans.
Proc Natl Acad Sci U S A
; 119(50): e2115328119, 2022 12 13.
Article
in English
| MEDLINE | ID: mdl-36469776
2.
Association between parity and pregnancy-associated tumor features in high-grade serous ovarian cancer.
Cancer Causes Control
; 2024 Apr 05.
Article
in English
| MEDLINE | ID: mdl-38578428
3.
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma.
Blood
; 140(21): 2248-2260, 2022 11 24.
Article
in English
| MEDLINE | ID: mdl-35839452
4.
Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2.
Acta Oncol
; 62(12): 1707-1715, 2023 Dec.
Article
in English
| MEDLINE | ID: mdl-37729083
5.
Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology.
Genes Chromosomes Cancer
; 61(1): 27-36, 2022 01.
Article
in English
| MEDLINE | ID: mdl-34647650
6.
Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes.
Int J Cancer
; 150(5): 773-781, 2022 03 01.
Article
in English
| MEDLINE | ID: mdl-34648676
7.
Outcomes of relapsed/refractory diffuse large B-cell lymphoma and influence of chimaeric antigen receptor T trial eligibility criteria in second line-A population-based study of 736 patients.
Br J Haematol
; 198(2): 267-277, 2022 07.
Article
in English
| MEDLINE | ID: mdl-35468219
8.
Checkpoint CD47 expression in classical Hodgkin lymphoma.
Br J Haematol
; 197(5): 580-589, 2022 06.
Article
in English
| MEDLINE | ID: mdl-35301709
9.
Advances in immune therapies in hematological malignancies.
J Intern Med
; 292(2): 205-220, 2022 08.
Article
in English
| MEDLINE | ID: mdl-34624160
10.
COVID-19 seroprevalence and clinical picture in Swedish pediatric oncology and hematology patients.
Pediatr Blood Cancer
; 69(10): e29773, 2022 10.
Article
in English
| MEDLINE | ID: mdl-35615775
11.
Superior outcome for splenectomised patients in a population-based study of splenic marginal zone lymphoma in Sweden.
Br J Haematol
; 194(3): 568-579, 2021 08.
Article
in English
| MEDLINE | ID: mdl-34109612
12.
Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study.
Br J Haematol
; 193(5): 906-914, 2021 06.
Article
in English
| MEDLINE | ID: mdl-33948942
13.
Boosting CAR T-cell responses in lymphoma by simultaneous targeting of CD40/4-1BB using oncolytic viral gene therapy.
Cancer Immunol Immunother
; 70(10): 2851-2865, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-33666760
14.
Prior antithymocyte globulin therapy and survival in post-transplant lymphoproliferative disorders.
Acta Oncol
; 60(6): 771-778, 2021 Jun.
Article
in English
| MEDLINE | ID: mdl-33793378
15.
Clinical characteristics and factors associated with COVID-19-related death and morbidity among hospitalized patients with cancer: a Swedish cohort study.
Acta Oncol
; 60(11): 1459-1465, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34334081
16.
PD-L1 and IDO1 are potential targets for treatment in patients with primary diffuse large B-cell lymphoma of the CNS.
Acta Oncol
; 60(4): 531-538, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-33579170
17.
No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy.
Br J Haematol
; 188(5): 685-691, 2020 03.
Article
in English
| MEDLINE | ID: mdl-31612478
18.
Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib.
BMC Cancer
; 20(1): 339, 2020 Apr 22.
Article
in English
| MEDLINE | ID: mdl-32321460
19.
Prognostic impact of abdominal lymph node involvement in diffuse large B-cell lymphoma.
Eur J Haematol
; 104(3): 207-213, 2020 Mar.
Article
in English
| MEDLINE | ID: mdl-31785002
20.
Outcome and determinants of failure to complete primary R-CHOP treatment for reasons other than non-response among patients with diffuse large B-cell lymphoma.
Am J Hematol
; 95(7): 740-748, 2020 07.
Article
in English
| MEDLINE | ID: mdl-32180274